Inventor · disambiguated record
Barbara Leuchs
Also filed as: LEUCHS BARBARA
14 granted patents·5 pending applications·20 citations·filing 2010–2024
88Inventor score
Files withDEUTSCHES KREBSFORSCH14DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS3LEUCHS BARBARA1ROMMELAERE JEAN1
Top patents by PatentIndex Score
19 records- 0186US10624935B2Parvovirus formulation for treating tumorsDEUTSCHES KREBSFORSCH·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0277US11193112B2Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particlesDEUTSCHES KREBSFORSCH·Filed 2019·Granted Dec 7, 2021·2 cites·7 claims
- 0376US10266810B2Method for large scale production and purification of parvovirusDEUTSCHES KREBSFORSCH·Filed 2016·Granted Apr 23, 2019·2 cites·9 claims
- 0472US9803219B2Adenovirus derived helper virus for enhancing recombinant parvovirus productionDEUTSCHES KREBSFORSCH·Filed 2012·Granted Oct 31, 2017·2 cites·9 claims
- 0571US9700588B2Use of parvovirus for eliminating cancer stem cells (CSCs)ROMMELAERE JEAN·Filed 2011·Granted Jul 11, 2017·3 cites·7 claims
- 0670US9333225B2Oncolytic virotherapy for the therapy of ewing'S sarcomaDEUTSCHES KREBSFORSCH·Filed 2013·Granted May 10, 2016·3 cites·3 claims
- 0769US11964015B2Cancer therapy with an oncolytic virus combined with a checkpoint inhibitorDEUTSCHES KREBSFORSCH·Filed 2021·Granted Apr 23, 2024·0 cites·6 claims
- 0868US8828400B2Antibody that binds to H-1 parvovirusLEUCHS BARBARA·Filed 2010·Granted Sep 9, 2014·4 cites·12 claims
- 0967US10227609B2Modified parvovirus useful for gene silencingDEUTSCHES KREBSFORSCH·Filed 2013·Granted Mar 12, 2019·1 cites·5 claims
- 1066US11027013B2Cancer therapy with an oncolytic virus combined with a checkpoint inhibitorDEUTSCHES KREBSFORSCH·Filed 2018·Granted Jun 8, 2021·0 cites·6 claims
- 1166US2025043251A1Method for further upscaling the large-scale production of the oncolytic h-1 protoparvovirus (h-1pv) using a carrier-based production process combined with an optimized cell culture mediumDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2024·Application pending·0 cites
- 1264US12404498B2Optimized parvovirus H-1 productionDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2021·Granted Sep 2, 2025·0 cites·13 claims
- 1363US2022290108A1Optimized method for large scale production of parvovirus h-1 in an essentially serum-free mediumDEUTSCHES KREBSFORSCH·Filed 2021·Application pending·0 cites
- 1462US2024182907A1H-1 PV EXPRESSING RNAi EFFECTORSDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2022·Application pending·0 cites
- 1560US11324788B2Parvovirus formulation for treating tumorsDEUTSCHES KREBSFORSCH·Filed 2020·Granted May 10, 2022·0 cites·17 claims
- 1658US2019203184A1Optimized method for large scale production of parvovirus h-1 in an essentially serum-free mediumDEUTSCHES KREBSFORSCH·Filed 2019·Application pending·0 cites
- 1750US9234183B2Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of its capsidDEUTSCHES KREBSFORSCH·Filed 2013·Granted Jan 12, 2016·0 cites·10 claims
- 1849US10525091B2Use of parvovirus for eliminating cancer stem cells (CSCs)DEUTSCHES KREBSFORSCH·Filed 2017·Granted Jan 7, 2020·0 cites·8 claims
- 1939US2020385738A1H-1 pv expressing rnai effectors targeting cdk9DEUTSCHES KREBSFORSCH·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →